Research has shown that ADAR1 targets miR-30a to regulate SOCS3 expression, thereby reducing IL-6 levels, mitigating inflammation and organ damage and providing protection against sepsis (Shangxun et al., 2020). The gene discussed is IL6; the disease is Sepsis.